Written by Cindy Dady, OCMS Executive Director
One of the issues that has been a determent in the fight against the drug abuse problem in Michigan has been the outdated Michigan Automated Prescription System (MAPS). MAPS, which went live in 2003, is the prescription monitoring program for the State of Michigan. Prescription monitoring programs are used to identify and prevent drug diversion at the prescriber, pharmacy and patient levels by collecting Schedule 2-5 controlled substances prescriptions, which include highly addictive drugs such as oxycodone and morphine, dispensed by pharmacies and practitioners.
Collection of this prescription information allows physicians, dentists, pharmacists, nurse practitioners, physician's assistants, podiatrists and veterinarians to query this data for patient-specific reports which allow a review of the patient's Schedules 2-5 controlled substance prescription records. This enables the practitioner to determine if patients are receiving controlled substances from other providers and to assist in the prevention of prescription drug abuse.*
The problem has been the system has many limitations, such as limited capacity, slow speed and a mismatch between those who use the system and those who should be required to use it. The old system also crashed regularly due to the increased demands of new users and prescriptions.
In 2015, Governor Snyder formed the Michigan Prescription Drug and Opioid Abuse Task Force to provide recommendations on how to best address the growing drug abuse problem in Michigan. Results of the task force included upgrading the MAPS system and in 2016 a budget of $2.4 million was approved for the upgrade.
Now the upgrade is almost complete and effective April 4, 2017, the Michigan Automated Prescription System (MAPS) will be using a new software called Appriss PMP AWARxE. Prior to the transition in April, users submitting prescription data to MAPS will be required to register with the Appriss' PMP Clearinghouse.
Those who submit data to MAPS must do the following:
If you have any questions on the transition, please contact the MAPS support team at (517) 373-1737 or by email at BPL-MAPS@michigan.gov.
MAPS Replacement Notification >>
Appriss Health's Prescription Drug Monitoring Solution, PMP AWARxE >>
*Michigan Department of Licensing and Regulatory Affairs
One of the issues that has been a determent in the fight against the drug abuse problem in Michigan has been the outdated Michigan Automated Prescription System (MAPS). MAPS, which went live in 2003, is the prescription monitoring program for the State of Michigan. Prescription monitoring programs are used to identify and prevent drug diversion at the prescriber, pharmacy and patient levels by collecting Schedule 2-5 controlled substances prescriptions, which include highly addictive drugs such as oxycodone and morphine, dispensed by pharmacies and practitioners.
Collection of this prescription information allows physicians, dentists, pharmacists, nurse practitioners, physician's assistants, podiatrists and veterinarians to query this data for patient-specific reports which allow a review of the patient's Schedules 2-5 controlled substance prescription records. This enables the practitioner to determine if patients are receiving controlled substances from other providers and to assist in the prevention of prescription drug abuse.*
The problem has been the system has many limitations, such as limited capacity, slow speed and a mismatch between those who use the system and those who should be required to use it. The old system also crashed regularly due to the increased demands of new users and prescriptions.
In 2015, Governor Snyder formed the Michigan Prescription Drug and Opioid Abuse Task Force to provide recommendations on how to best address the growing drug abuse problem in Michigan. Results of the task force included upgrading the MAPS system and in 2016 a budget of $2.4 million was approved for the upgrade.
Now the upgrade is almost complete and effective April 4, 2017, the Michigan Automated Prescription System (MAPS) will be using a new software called Appriss PMP AWARxE. Prior to the transition in April, users submitting prescription data to MAPS will be required to register with the Appriss' PMP Clearinghouse.
Those who submit data to MAPS must do the following:
- Correct all errors prior to submitting data to MAPS
- Existing users of PMP Clearinghouse will not need to register with the new system
- New users to PMP Clearinghouse will need to register beginning Wednesday, March 8, 2017
- If you have a software vendor who submits data on your behalf, please ensure they are aware of the upcoming changes
If you have any questions on the transition, please contact the MAPS support team at (517) 373-1737 or by email at BPL-MAPS@michigan.gov.
MAPS Replacement Notification >>
Appriss Health's Prescription Drug Monitoring Solution, PMP AWARxE >>
*Michigan Department of Licensing and Regulatory Affairs
RSS Feed
